Skip to main content

Table 3 Results of analyses of commercial products for albendazole

From: Development and application of a spectrophotometric method in quality evaluation of benzimidazole anthelminthics in Nairobi city county

Product code

Dosage form

Batch

Assay (%)

Commenta

A001S

Suspension

1

107.3

Complies

2

108.4

Complies

3

107.3

Complies

A001T

Tablets

1

96.6

Complies

2

98.6

Complies

3

100.1

Complies

A002S

Suspension

1

104.1

Complies

2

105.0

Complies

A002T

Tablets

1

98.3

Complies

2

145.4

Does not comply

3

96.9

Complies

A003S

Suspension

1

98.0

Complies

2

97.1

Complies

3

96.2

Complies

A003T

Tablets

1

96.8

Complies

2

99.6

Complies

A004S

Suspension

1

100.2

Complies

A004T

Tablets

1

97.2

Complies

2

95.9

Complies

A005S

Suspension

1

87.2

Does not comply

A005T

Tablets

1

103.3

Complies

A006T

Tablets

1

93.3

Complies

A007S

Suspension

1

109.0

Complies

A008T

Tablets

1

100.3

Complies

A009S

Suspension

1

7.9

Does not comply

  1. aUSP 2018 specification for content (not less than 90.0% and not more than 110.0% of the label claim)